Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration
NCT01600300 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-05-17
Summary
Hypothesis: external electrical stimulation of the retina with low level electrical currents improves visual acuity in subjects with age-related dry macular degeneration.
Conditions
- Macular Degeneration
Interventions
- DEVICE
-
Tesmac
Subjects were treated twice daily for five consecutive days, followed by two days untreated, and then treated twice daily for five more consecutive days.
- DEVICE
-
Sham Tesmac device
Treatment with inactivated Tesmac device on the same schedule as the group treated with the active Tesmac device.
Sponsors & Collaborators
-
Acuity Medical International, Inc.
lead INDUSTRY
Principal Investigators
-
Richard Beauchemin, MD · WNC Eye Care Associates PA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-08-31
- Primary Completion
- 2004-04-30
- Completion
- 2004-04-30
More Related Trials
-
Microcurrent Stimulation for Dry Age-related Macular Degeneration
NCT04511936 ·Status: WITHDRAWN ·Phase: NA
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
NCT02725762 ·Status: COMPLETED ·Phase: NA
-
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
NCT00447954 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
NCT04065490 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
NCT06242379 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
NCT00100087 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
NCT01922128 ·Status: COMPLETED ·Phase: PHASE1
-
Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
NCT00100009 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT02087085 ·Status: TERMINATED ·Phase: PHASE2
-
Photobiomodulation in Dry Age Related Macular Degeneration
NCT06046118 ·Status: RECRUITING ·Phase: NA
-
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
NCT02127463 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)
NCT00658619 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)
NCT03878420 ·Status: COMPLETED ·Phase: NA
-
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
NCT04339764 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases
NCT04008771 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration
NCT01601483 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
NCT00940407 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Therapy in Age-Related Macular Degeneration (ARMD)
NCT00805649 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes
NCT01846351 ·Status: COMPLETED
-
Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
NCT01518127 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
NCT06737354 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
A Study of NGM621 in Participants With Geographic Atrophy
NCT04465955 ·Status: COMPLETED ·Phase: PHASE2
-
Non-invasive Ultrasound Retinal Stimulation for Vision Restoration
NCT05914233 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
NCT03525613 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
NCT02873351 ·Status: WITHDRAWN ·Phase: PHASE2